The new JAMA Surgery review, released on January 8 2025, offers surgeons and medical researchers a straightforward roadmap for using artificial intelligence, chatbots, and large language models (LLMs) in every stage of a study. Rather than getting lost in technical jargon, the guide walks readers through real‑world examples—showing how AI can help design experiments, clean messy data, generate clear visualizations, and even draft manuscript sections. It also highlights common pitfalls, such as bias in training data and the importance of transparent reporting, so clinicians can avoid missteps that could affect patient care. Practical tips include selecting the right AI tool for a specific task, integrating chat‑based assistants into literature reviews, and using LLMs to summarize complex findings for multidisciplinary teams. The authors stress ethical considerations, data privacy, and the need for peer‑reviewed validation of AI‑generated results. By the end of the guide, surgeons will feel confident leveraging cutting‑edge technology to speed up research, improve accuracy, and communicate their discoveries more effectively—all without needing a PhD in computer science.
Read moreBoston Scientific disclosed that a cyber‑security breach discovered on Aug. 25 temporarily knocked out key IT systems, halting order processing and disrupting parts of its global operations. The attack forced the company to pause shipments and slowed manufacturing at several sites, prompting concerns that the incident could dent its upcoming financial results. In a fresh update, the firm announced that all sterilization facilities are now fully operational and back to processing products, and that manufacturing has resumed at most of its plants worldwide. Additional production capacity is being brought online as the company continues to restore its digital infrastructure. While the breach highlighted vulnerabilities in the company’s data networks, Boston Scientific says the swift recovery of critical facilities limits the long‑term impact on revenue. Investors are watching closely as the company works to fully normalize its supply chain and reassure customers that product quality and safety remain uncompromised. The episode serves as a reminder of how cyber threats can ripple through the medical‑device industry, affecting everything from order fulfillment to quarterly earnings.
Read more